Additional Information
Market: LSE
Sector: Food Producers
EPIC: TATE
Latest Price: 695.00p  (0.65% Ascending)
52-week High: 729.50p
52-week Low: 449.50p
Market Cap: 3,242.71M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Tate & Lyle
www.tateandlyle.com
Tate & Lyle PLC (Tate & Lyle) is engaged in the development, manufacture and marketing of food and industrial ingredients that have been made from renewable sources. The Company operates through four divisions: Food & Industrial Ingredients, Americas; Food & Industrial Ingredients, Europe; Sucralose and Sugars. Tate & Lyle has more than 50 production worldwide. The Company participates mainly in four markets: food and beverage; industrial; pharmaceutical and personal care, and animal feed. On June 15, 2007, the Company acquired 80% of G.C. Hahn & Co. (Hahn). Hahn provides customized ingredient solutions to global customers. On April 22, 2007, the Company disposed of its shareholding in Tate & Lyle Canada (Redpath). On December 28, 2007, the Company disposed of its 49% indirect shareholding in Grupo Industrial Azucarero de Occidente, S.A. de C.V. (Occidente). In July 2008, the Company announced the sale of its international sugar trading operations to Bunge Limited
Pdf

Tate & Lyle Interims Ahead Of Expectations Despite Challenging Trading Environment

6th Nov 2009, 9:27 am Tate & Lyle Interims Ahead Of Expectations Despite Challenging Trading Environment

Tate & Lyle (LSE: TATE) released their latest half-yearly report this morning in which it revealed it had increased sales by 7% during the period and reduced its net debt by 20% since March. The results are ‘slightly ahead of expectations’ and the group is said to be encouraged by the progress in the six months to 30th September.


In a ‘challenging’ environment the company’s overall performance is being supported through it’s ‘core value added food ingredients’ division, which reported a 10% increase in adjusted operating profit in the period.


Across the whole group, adjusted operating profit was reduced by 1% to £148 million. However statutory profit before tax reduced by 59% following £55 million in exceptional costs due to the decision to mothball the sucralose plant in McIntosh, Alabama.


According to today’s statement the Group's performance remains on track to meet expectations for the full year (before the impact of exchange translation), with the Food & Industrial Ingredients businesses appearing to be re-established at slightly lower levels.


The group expects continued underlying growth in Sucralose and improved profits from Sugars in the second half. However Tate & Lyle also indicate that its global industrial starch, US ethanol and US animal feed markets remain under pressure.

 Tate & Lyle Chief Executive, Javed Ahmed commented on the group’s performance for the first half of the financial year: “Tate & Lyle performed slightly ahead of our expectations in the first half of the year, before the impact of exchange translation, despite challenging conditions in a number of our markets. We are encouraged by the good progress made in reducing net debt, reflecting our focus on reducing costs, optimising working capital and reducing capital expenditure.”

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.